Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.7
Avid Bioservices, Inc. reported a default on credit facility of No amounts are outstanding under the Company’s Credit Agreement with Bank of America, N.A..
- Instrument
- credit facility
- Principal
- No amounts are outstanding under the Company’s Credit Agreement
- Counterparty
- Bank of America, N.A.
- Event
- default
Exact text from the filing
As a result of the Acceleration Event, such occurrence also resulted in a cross-default under the Company’s Credit Agreement with Bank of America, N.A. (the “Revolving Lender”)
View on SEC.gov
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
Avid Bioservices, Inc. faced acceleration on convertible notes of approximately $146.0 million with holder of its 1.250% Exchangeable Senior Notes due 2026 at 2.75% per annum until paid in full maturing due 2026.
- Instrument
- convertible notes
- Principal
- approximately $146.0 million
- Counterparty
- holder of its 1.250% Exchangeable Senior Notes due 2026
- Rate
- 2.75% per annum until paid in full
- Maturity
- due 2026
- Event
- acceleration
Exact text from the filing
(the “Acceleration Event”). The accelerated amount, inclusive of principal and interest due and payable, as of February 29, 2024, the date of acceleration, was approximately $146.0 million and accrues interest at 2.75% per annum until paid in full. The Company did not receive any notices and was not otherwise made aware of the Event of Default prior to receipt of
View on SEC.gov